A Comparative Study of Escitalopram and Citalopram in the Treatment of Depression
Guang Shu
Abstract
Guang Shu
Abstract
Objective:To compare the clinical efficacy and safety of escitalopram and citalopram in the treatment of Depression.Method: 80 patients with Depression were randomly divided into escitalopram group and citalopram group.The course of treatments was 8 weeks.The therepeutic effects were evaluated by Hamilton rating scale for depression(HAMD),and side effects were assessed by treatment emergent symptom scale(TESS).Result: The efficacy rate of escitalopram group were 85% and citalpram group were 82.5% and there was a significantly difference(P=0.025),The effect of escitalopram is more quickly than citalopram and side effect of all of them is less.Conclusion: Escitalopram is one of effective antidepression.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To compare the clinical efficacy and safety of escitalopram and citalopram in the treatment of Depression.Method: 80 patients with Depression were randomly divided into escitalopram group and citalopram group.The course of treatments was 8 weeks.The therepeutic effects were evaluated by Hamilton rating scale for depression(HAMD),and side effects were assessed by treatment emergent symptom scale(TESS).Result: The efficacy rate of escitalopram group were 85% and citalpram group were 82.5% and there was a significantly difference(P=0.025),The effect of escitalopram is more quickly than citalopram and side effect of all of them is less.Conclusion: Escitalopram is one of effective antidepression.
Key concepts: Escitalopram, Citalopram, Medicine, Hamd, Depression (economics), Significant difference, Rating scale, Internal medicine